Mirae Asset Global Investments Co. Ltd. Purchases 3,249 Shares of The Clorox Company (NYSE:CLX)

Mirae Asset Global Investments Co. Ltd. increased its holdings in The Clorox Company (NYSE:CLX) by 21.3% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 18,508 shares of the company’s stock after purchasing an additional 3,249 shares during the period. Mirae Asset Global Investments Co. Ltd.’s holdings in Clorox were worth $3,013,000 at the end of the most recent quarter.

Several other large investors also recently bought and sold shares of the business. Mizuho Securities USA LLC increased its position in shares of Clorox by 46,877.8% during the 3rd quarter. Mizuho Securities USA LLC now owns 4,500,000 shares of the company’s stock valued at $733,095,000 after purchasing an additional 4,490,421 shares during the last quarter. Ilex Capital Partners UK LLP increased its position in Clorox by 512.7% during the third quarter. Ilex Capital Partners UK LLP now owns 542,110 shares of the company’s stock valued at $88,315,000 after acquiring an additional 453,624 shares during the last quarter. International Assets Investment Management LLC increased its position in Clorox by 424.9% during the third quarter. International Assets Investment Management LLC now owns 538,576 shares of the company’s stock valued at $877,390,000 after acquiring an additional 435,971 shares during the last quarter. Boston Trust Walden Corp lifted its holdings in shares of Clorox by 5,442.5% in the 3rd quarter. Boston Trust Walden Corp now owns 273,908 shares of the company’s stock worth $44,622,000 after acquiring an additional 268,966 shares during the last quarter. Finally, Assenagon Asset Management S.A. boosted its stake in shares of Clorox by 302.0% during the 4th quarter. Assenagon Asset Management S.A. now owns 353,367 shares of the company’s stock worth $57,390,000 after purchasing an additional 265,455 shares during the period. Institutional investors own 78.53% of the company’s stock.

Clorox Price Performance

NYSE CLX opened at $148.51 on Monday. The company has a market cap of $18.38 billion, a PE ratio of 40.58, a P/E/G ratio of 2.52 and a beta of 0.42. The firm’s 50 day moving average price is $161.06 and its 200-day moving average price is $158.88. The company has a debt-to-equity ratio of 20.52, a quick ratio of 0.62 and a current ratio of 0.94. The Clorox Company has a 52-week low of $127.60 and a 52-week high of $171.37.

Clorox (NYSE:CLX) last announced its earnings results on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same quarter in the previous year, the firm posted $2.16 EPS. Sell-side analysts forecast that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be given a dividend of $1.22 per share. This represents a $4.88 annualized dividend and a dividend yield of 3.29%. The ex-dividend date of this dividend is Wednesday, January 29th. Clorox’s payout ratio is 133.33%.

Wall Street Analyst Weigh In

CLX has been the topic of a number of recent analyst reports. TD Cowen raised shares of Clorox from a “sell” rating to a “hold” rating and increased their price objective for the stock from $155.00 to $170.00 in a research report on Wednesday, November 6th. Royal Bank of Canada reissued a “sector perform” rating and set a $150.00 price target on shares of Clorox in a research note on Thursday, January 30th. Wells Fargo & Company boosted their price objective on Clorox from $157.00 to $161.00 and gave the company an “equal weight” rating in a report on Tuesday, February 4th. Evercore ISI increased their target price on Clorox from $145.00 to $155.00 in a research note on Tuesday, February 4th. Finally, DA Davidson lowered their target price on shares of Clorox from $171.00 to $169.00 and set a “neutral” rating for the company in a research note on Wednesday, February 5th. Four equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has assigned a buy rating to the stock. According to data from MarketBeat, Clorox presently has an average rating of “Hold” and a consensus target price of $158.21.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.